What was the overall market valuation of the pharmacovigilance market in 2024?

The overall market valuation was $157.06 Million in 2024. Read More

What is the projected market valuation for 2035?

The projected market valuation for 2035 is $619.4 Million. Read More

What is the expected CAGR for the pharmacovigilance market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 13.29%. Read More

Which service type segment had the highest valuation in 2024?

The pharmacovigilance consulting segment had the highest valuation at $249.4 Million in 2024. Read More

What are the two deployment modes in the pharmacovigilance market?

The two deployment modes are Cloud-Based, valued at $280 Million, and On-Premise, valued at $339.4 Million. Read More

Which end user segment contributed the most to the market in 2024?

The pharmaceutical companies segment contributed the most, with a valuation of $320 Million in 2024. Read More

What is the valuation range for the data mining service type segment?

The valuation range for the data mining service type segment is from $40.0 Million to $150.0 Million. Read More

Which key player is associated with the pharmacovigilance market?

Key players in the market include Parexel International, Covance, and IQVIA. Read More

What was the valuation for spontaneous reporting in 2024?

The valuation for spontaneous reporting was $160 Million in 2024. Read More

What is the projected growth trend for the pharmacovigilance market in South Korea?

The market is expected to grow significantly, reaching $619.4 Million by 2035. Read More

South Korea Pharmacovigilance Market

ID: MRFR/MED/49096-HCR

200 Pages

Nidhi Mandole

Last Updated: April 06, 2026

South Korea Pharmacovigilance Market Research Report: Size, Share, Trend Analysis By Service Type (Adverse Event Reporting, Risk Assessment, Data Mining, Pharmacovigilance Consulting), By Deployment Mode (Cloud-Based, On-Premise), By Source (Spontaneous Reporting, Literature Reports, Scheduled Reporting) and By End Users (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Pharmacovigilance Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)13.29%

2024 Market Size$ 157.06 Million

2025 Market Size$ 177.94 Million

2035 Market Size$ 619.4 Million

Key Players

Parexel International

Covance

IQVIA

Wuxi AppTec

Syneos Health

Medpace

Trends

Regulatory Compliance and Safety Monitoring
Technological Advancements in Data Management
Increased Collaboration Among Stakeholders

Opportunities

Increased Regulatory Scrutiny
Rising Demand for Drug Safety
Expansion of Biopharmaceuticals

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Service Type (USD Million)
  1. 4.1.1 Adverse Event Reporting
  2. 4.1.2 Risk Assessment
  3. 4.1.3 Data Mining
  4. 4.1.4 Pharmacovigilance Consulting
2. 4.2 Life Sciences, BY Deployment Mode (USD Million)
  1. 4.2.1 Cloud-Based
  2. 4.2.2 On-Premise
3. 4.3 Life Sciences, BY Source (USD Million)
  1. 4.3.1 Spontaneous Reporting
  2. 4.3.2 Literature Reports
  3. 4.3.3 Scheduled Reporting
4. 4.4 Life Sciences, BY End User (USD Million)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Companies
  3. 4.4.3 Contract Research Organizations
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Parexel International (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Covance (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 IQVIA (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Wuxi AppTec (CN)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Syneos Health (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Medpace (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Charles River Laboratories (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 PRA Health Sciences (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY DEPLOYMENT MODE
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY SOURCE
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY SERVICE TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY DEPLOYMENT MODE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY DEPLOYMENT MODE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY SOURCE, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY SOURCE, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DEPLOYMENT MODE, 2025-2035 (USD Million)
  3. 7.2.3 BY SOURCE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Life Sciences Market Segmentation

Life Sciences By Service Type (USD Million, 2025-2035)

Adverse Event Reporting
Risk Assessment
Data Mining
Pharmacovigilance Consulting

Life Sciences By Deployment Mode (USD Million, 2025-2035)

Cloud-Based
On-Premise

Life Sciences By Source (USD Million, 2025-2035)

Spontaneous Reporting
Literature Reports
Scheduled Reporting

Life Sciences By End User (USD Million, 2025-2035)

Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”